Xeris Biopharma Holdings, Inc. (XERS)

6.37 +0.25 (+4.08%) USD  |  NASDAQ  |  Apr 17, 16:00
6.37 0.00 (0.00%) Pre-Market: 20:00
More

Xeris Biopharma Holdings Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for XERS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
IDEXX Laboratories, Inc. Upgrade
Zoetis, Inc. Upgrade
Harrow, Inc. Upgrade
Zymeworks, Inc. Upgrade
Vir Biotechnology, Inc. Upgrade